Showing 271-280 of 756 results for "".
The Biggest Developments in Dermatology: Drs. Tsao and Friedlander Provide Updates at Maui Derm
https://practicaldermatology.com/issues/january-february-2025/the-biggest-developments-in-dermatology-drs-tsao-and-friedlander-provide-updates-at-maui-derm/32937/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, adopted a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.To Attenuate the Skin Cancer Epidemic, Start Early
https://practicaldermatology.com/topics/skin-cancer-photoprotection/to-end-the-skin-cancer-epidemic-start-early/20719/UV education and good SPF habits for children are essential to reversing worrisome skin cancer trends.Reversing Cicatricial Ectropion Related to Chronic Periocular Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/reversing-cicatricial-ectropion-related-to-chronic-periocular-atopic-dermatitis/23752/Robotic Technology Brings New Benefits to Patients and Practices
https://practicaldermatology.com/topics/general-topics/robotic-technology-brings-new-benefits-to-patients-and-practices/21501/Can the new trend in robotic surgery benefit cosmetic dermatology practices?How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivSystemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.When to Consider Therapeutic Switching in Plaque Psoriasis: Best Practices for Nurse Practitioners, Physician Assistants, and Physicians
https://practicaldermatology.com/topics/psoriasis/when-to-consider-therapeutic-switching-in-plaque-psoriasis-best-practices-for-nurse-practitioners-physician-assistants-and-physicians/21054/What to know about patient experiences and the proper approaches to modifying treatment regimens.The Mind-Skin Connection: Psoriasis and Psychological Comorbidities
https://practicaldermatology.com/issues/supplements/the-mind-skin-connection-psoriasis-and-psychological-comorbidities/20833/A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to Dian